These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 27075228)

  • 1. Structural insights and functional implications of inter-individual variability in β2-adrenergic receptor.
    Tandale A; Joshi M; Sengupta D
    Sci Rep; 2016 Apr; 6():24379. PubMed ID: 27075228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular insights into the dynamics of pharmacogenetically important N-terminal variants of the human β2-adrenergic receptor.
    Shahane G; Parsania C; Sengupta D; Joshi M
    PLoS Comput Biol; 2014 Dec; 10(12):e1004006. PubMed ID: 25501358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding the conformation transition in the activation pathway of β2 adrenergic receptor via a targeted molecular dynamics simulation.
    Xiao X; Zeng X; Yuan Y; Gao N; Guo Y; Pu X; Li M
    Phys Chem Chem Phys; 2015 Jan; 17(4):2512-22. PubMed ID: 25494239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterizing clinically relevant natural variants of GPCRs using computational approaches.
    Sengupta D; Sonar K; Joshi M
    Methods Cell Biol; 2017; 142():187-204. PubMed ID: 28964336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of allosteric regulation of β
    Manna M; Niemelä M; Tynkkynen J; Javanainen M; Kulig W; Müller DJ; Rog T; Vattulainen I
    Elife; 2016 Nov; 5():. PubMed ID: 27897972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights into the role of Asp79(2.50) in β2 adrenergic receptor activation from molecular dynamics simulations.
    Ranganathan A; Dror RO; Carlsson J
    Biochemistry; 2014 Nov; 53(46):7283-96. PubMed ID: 25347607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic behavior of fully solvated beta2-adrenergic receptor, embedded in the membrane with bound agonist or antagonist.
    Spijker P; Vaidehi N; Freddolino PL; Hilbers PA; Goddard WA
    Proc Natl Acad Sci U S A; 2006 Mar; 103(13):4882-7. PubMed ID: 16551744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding the effects on constitutive activation and drug binding of a D130N mutation in the β2 adrenergic receptor via molecular dynamics simulation.
    Zhu Y; Yuan Y; Xiao X; Zhang L; Guo Y; Pu X
    J Mol Model; 2014 Nov; 20(11):2491. PubMed ID: 25342155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GPCR engineering yields high-resolution structural insights into beta2-adrenergic receptor function.
    Rosenbaum DM; Cherezov V; Hanson MA; Rasmussen SG; Thian FS; Kobilka TS; Choi HJ; Yao XJ; Weis WI; Stevens RC; Kobilka BK
    Science; 2007 Nov; 318(5854):1266-73. PubMed ID: 17962519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of a water-mediated network results in reduced agonist affinity in a β
    Nikte SV; Sonar K; Tandale A; Joshi M; Sengupta D
    Biochim Biophys Acta Proteins Proteom; 2021 Apr; 1869(4):140605. PubMed ID: 33453412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential Dynamics Underlying the Gln27Glu Population Variant of the β
    Bhosale S; Nikte SV; Sengupta D; Joshi M
    J Membr Biol; 2019 Oct; 252(4-5):499-507. PubMed ID: 31520159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How To Minimize Artifacts in Atomistic Simulations of Membrane Proteins, Whose Crystal Structure Is Heavily Engineered: β₂-Adrenergic Receptor in the Spotlight.
    Manna M; Kulig W; Javanainen M; Tynkkynen J; Hensen U; Müller DJ; Rog T; Vattulainen I
    J Chem Theory Comput; 2015 Jul; 11(7):3432-45. PubMed ID: 26575777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping the functional binding sites of cholesterol in β2-adrenergic receptor by long-time molecular dynamics simulations.
    Cang X; Du Y; Mao Y; Wang Y; Yang H; Jiang H
    J Phys Chem B; 2013 Jan; 117(4):1085-94. PubMed ID: 23298417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular determinants of GPCR pharmacogenetics: Deconstructing the population variants in β
    Joshi M; Nikte SV; Sengupta D
    Adv Protein Chem Struct Biol; 2022; 128():361-396. PubMed ID: 35034724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural insights into positive and negative allosteric regulation of a G protein-coupled receptor through protein-lipid interactions.
    Bruzzese A; Gil C; Dalton JAR; Giraldo J
    Sci Rep; 2018 Mar; 8(1):4456. PubMed ID: 29535353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the interactions between β2 adrenergic receptor and Gs protein by molecular dynamics simulations.
    Feng Z; Hou T; Li Y
    J Chem Inf Model; 2012 Apr; 52(4):1005-14. PubMed ID: 22404225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of agonist stimulation of cAMP-dependent protein kinase and G protein-coupled receptor kinase phosphorylation of the beta2-adrenergic receptor using phosphoserine-specific antibodies.
    Tran TM; Friedman J; Qunaibi E; Baameur F; Moore RH; Clark RB
    Mol Pharmacol; 2004 Jan; 65(1):196-206. PubMed ID: 14722251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detergent- and phospholipid-based reconstitution systems have differential effects on constitutive activity of G-protein-coupled receptors.
    Staus DP; Wingler LM; Pichugin D; Prosser RS; Lefkowitz RJ
    J Biol Chem; 2019 Sep; 294(36):13218-13223. PubMed ID: 31362983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural basis for ligand binding and specificity in adrenergic receptors: implications for GPCR-targeted drug discovery.
    Huber T; Menon S; Sakmar TP
    Biochemistry; 2008 Oct; 47(42):11013-23. PubMed ID: 18821775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural bioinformatics analysis of variants on GPCR function.
    Syed Haneef SA; Ranganathan S
    Curr Opin Struct Biol; 2019 Apr; 55():161-177. PubMed ID: 31174013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.